A report from the avian influenza vaccination task force, which looked at how best to manage highly pathogenic avian ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

The government already has three licensed, stockpiled vaccines for bird flu, but they don’t match current strains of the virus. That’s why the HHS, under President Biden, awarded Moderna more than ...

The Department of Health and Human Service is pulling millions of dollars in funding for a human bird flu vaccine developed by Covid vaccine-maker Moderna. Before President Donald Trump took ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United States is in the midst of an ...

NEW YORK/LONDON (Reuters) - The first human tests of experimental vaccines against a deadly strain of avian flu, using novel technology that could produce millions of doses very quickly, has ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before they ignite a human pandemic.Now, a team of scientists has developed a ...

May 29, 2025 – The Department of Health and Human Services (HHS) has terminated funding for a major trial testing the safety and efficacy of a vaccine to protect Americans from bird flu, should the ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.